Correlation Between Seelos Therapeutics and GH Research

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Seelos Therapeutics and GH Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seelos Therapeutics and GH Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seelos Therapeutics and GH Research PLC, you can compare the effects of market volatilities on Seelos Therapeutics and GH Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seelos Therapeutics with a short position of GH Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seelos Therapeutics and GH Research.

Diversification Opportunities for Seelos Therapeutics and GH Research

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Seelos and GHRS is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Seelos Therapeutics and GH Research PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GH Research PLC and Seelos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seelos Therapeutics are associated (or correlated) with GH Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GH Research PLC has no effect on the direction of Seelos Therapeutics i.e., Seelos Therapeutics and GH Research go up and down completely randomly.

Pair Corralation between Seelos Therapeutics and GH Research

Given the investment horizon of 90 days Seelos Therapeutics is expected to under-perform the GH Research. In addition to that, Seelos Therapeutics is 2.23 times more volatile than GH Research PLC. It trades about -0.13 of its total potential returns per unit of risk. GH Research PLC is currently generating about 0.01 per unit of volatility. If you would invest  1,140  in GH Research PLC on August 25, 2024 and sell it today you would lose (213.00) from holding GH Research PLC or give up 18.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.2%
ValuesDaily Returns

Seelos Therapeutics  vs.  GH Research PLC

 Performance 
       Timeline  
Seelos Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Seelos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
GH Research PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GH Research PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Seelos Therapeutics and GH Research Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Seelos Therapeutics and GH Research

The main advantage of trading using opposite Seelos Therapeutics and GH Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seelos Therapeutics position performs unexpectedly, GH Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GH Research will offset losses from the drop in GH Research's long position.
The idea behind Seelos Therapeutics and GH Research PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years